Background and Purpose: There are many researches about the relationship between dyslipidemia and the risk of stroke in the world. The results of these researches confirmed that dyslipidemia is the risky factor of ischemic stroke and the benefit of treatment for lipid-lowering on ischemic stroke, but for hemorrhagic stroke has not been clear. In Vietnam, a few studies about each ingredient of dyslipidemia in stroke have been carried out. Methods: The author studied on 116 patients with hemorrhagic stroke and 136 patients with ischemic stroke in Stroke Centre of Central Military Hospital No.108. All patients had been measured in total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triqlvceride (TG)
and the results between two groups of patients were compared. Results: - There was no difference ofTG between two groups of patients. - The TC, LDL-C in the group of patients with ischemic stroke (5.1 + or - 0.8mmol/l
3.36 + or - 0.93mmol/l) were higher than that in the group of patients with hemorrhagic stroke (4.7 + or - 1.13mmol/l
2.75 + or - 1.0mmolll) respectively p 0.05
- Percentage of the total dyslipidemia, the high level of TC, LDL-C and the low level of HDL-C in the group of patients with ischemic stroke (82 percent
47.8 percent
46.3 percent, 27.5 percent) were higher than that in the group of patients with hemorrhagic stroke (61 percent
29.3 percent
27.6 percent
7.8 percent). Conclusions: It is needed to treat dyslipidemia for the secondary prevention of ischemic stroke.